Publication

Zhang H, Lund DM, Ciccone HA, Staatz WD, Ibrahim MM, Largent-Milnes TM, Seltzman HH, Spigelman I, Vanderah TW. 2018. Peripherally restricted cannabinoid 1 receptor agonist as a novel analgesic in cancer-induced bone pain. Pain. 159:1814–1823. doi:10.1097/j.pain.0000000000001278.

Menghrajani K, Boonstra PS, Mercer JA, Perkins C, Gowin KL, Weber AA, Mesa R, Gotlib JR, Wang L, Singer JW, et al. 2018 Sep. Predictive models for splenic response to JAK-inhibitor therapy in patients with myelofibrosis. Leuk Lymphoma.:1–7. doi:10.1080/10428194.2018.1509315.

Smalls BL, Aroh A, McQuerry K, Adegboyega A, Schoenberg N, Hatcher J. 2018. Social support and breast cancer screening in rural Appalachia. Psychooncology. 27:2281–2288. doi:10.1002/pon.4828.

Peters TL, Tillotson J, Yeomans AM, Wilmore S, Lemm E, Jiménez-Romero C, Amador LA, Li L, Amin AD, Pongtornpipat P, et al. 2018. Target-Based Screening against eIF4A1 Reveals the Marine Natural Product Elatol as a Novel Inhibitor of Translation Initiation with Antitumor Activity. Clin Cancer Res. 24:4256–4270. doi:10.1158/1078-0432.CCR-17-3645.

Persky DO, Li H, Rimsza LM, Barr PM, Popplewell LL, Bane CL, Von Gehr A, LeBlanc M, Fisher RI, Smith SM, et al. 2018. A phase I/II trial of vorinostat (SAHA) in combination with rituximab-CHOP in patients with newly diagnosed advanced stage diffuse large B-cell lymphoma (DLBCL): SWOG S0806. Am J Hematol. 93:486–493. doi:10.1002/ajh.25010.

Hamann HA, Shen MJ, Thomas AJ, Craddock Lee SJ, Ostroff JS. 2018. Development and Preliminary Psychometric Evaluation of a Patient-Reported Outcome Measure for Lung Cancer Stigma: The Lung Cancer Stigma Inventory (LCSI). Stigma Health. 3:195–203. doi:10.1037/sah0000089.

Malm SW, Amouzougan EA, Klimecki WT. 2018. Fetal bovine serum induces sustained, but reversible, epithelial-mesenchymal transition in the BEAS-2B cell line. Toxicol In Vitro. 50:383–390. doi:10.1016/j.tiv.2018.04.008.

Bergsma A, Ganguly SS, Dick D, Williams BO, Miranti CK. 2018. Global deletion of tetraspanin CD82 attenuates bone growth and enhances bone marrow adipogenesis. Bone. 113:105–113. doi:10.1016/j.bone.2018.05.020.

Dellinger MT, Witte MH. 2018. Lymphangiogenesis, lymphatic systemomics, and cancer: context, advances and unanswered questions. Clin Exp Metastasis. 35:419–424. doi:10.1007/s10585-018-9907-9.

Das L, Gard JMC, Prekeris R, Nagle RB, Morrissey C, Knudsen BS, Miranti CK, Cress AE. 2018. Novel Regulation of Integrin Trafficking by Rab11-FIP5 in Aggressive Prostate Cancer. Mol Cancer Res. 16:1319–1331. doi:10.1158/1541-7786.MCR-17-0589.

Glazer AM, Stratton D, Curiel-Lewandrowski C. 2018. Potential Underuse of the Sentinel Lymph Node Biopsy for High-Risk Squamous Cell Carcinoma of the Skin. JAMA Dermatol. 154:972–973. doi:10.1001/jamadermatol.2018.1807.

Tariqul Islam AFM, Yue H, Scavello M, Haldeman P, Rappel W-J, Charest PG. 2018. The cAMP-induced G protein subunits dissociation monitored in live Dictyostelium cells by BRET reveals two activation rates, a positive effect of caffeine and potential role of microtubules. Cell Signal. 48:25–37. doi:10.1016/j.cellsig.2018.04.005.

Knitter JR, Erly WK, Stea BD, Lemole GM, Germano IM, Doshi AH, Nael K. 2018. Interval Change in Diffusion and Perfusion MRI Parameters for the Assessment of Pseudoprogression in Cerebral Metastases Treated With Stereotactic Radiation. AJR Am J Roentgenol. 211:168–175. doi:10.2214/AJR.17.18890.

de la Vega MR, Chapman E, Zhang DD. 2018. NRF2 and the Hallmarks of Cancer. Cancer Cell. 34:21–43. doi:10.1016/j.ccell.2018.03.022.

Daenthanasanmak A, Wu Y, Iamsawat S, Nguyen HD, Bastian D, Zhang M, Sofi MH, Chatterjee S, Hill EG, Mehrotra S, et al. 2018. PIM-2 protein kinase negatively regulates T cell responses in transplantation and tumor immunity. J Clin Invest. 128:2787–2801. doi:10.1172/JCI95407.

Lin A, Kupinski MA, Peterson TE, Shokouhi S, Johnson LC. 2018. Task-based design of a synthetic-collimator SPECT system used for small animal imaging. Med Phys. 45:2952–2963. doi:10.1002/mp.12952.

Stewart DB, Gaertner WB, Glasgow SC, Herzig DO, Feingold D, Steele SR. 2018. The American Society of Colon and Rectal Surgeons Clinical Practice Guidelines for Anal Squamous Cell Cancers (Revised 2018). Dis Colon Rectum. 61:755–774. doi:10.1097/DCR.0000000000001114.

Wilkinson EM, Ilhan ZE, Herbst-Kralovetz MM. 2018. Microbiota-drug interactions: Impact on metabolism and efficacy of therapeutics. Maturitas. 112:53–63. doi:10.1016/j.maturitas.2018.03.012.

Calton CM, Kelly KR, Anwer F, Carew JS, Nawrocki ST. 2018. Oncolytic Viruses for Multiple Myeloma Therapy. Cancers (Basel). 10. doi:10.3390/cancers10060198.

Weinstein RS, Krupinski EA, Doarn CR. 2018. Clinical Examination Component of Telemedicine, Telehealth, mHealth, and Connected Health Medical Practices. Med Clin North Am. 102:533–544. doi:10.1016/j.mcna.2018.01.002.

Olek D, El-Ghamry MN, Deb N, Thawani N, Shaver C, Mutyala S. 2018. Custom mold applicator high-dose-rate brachytherapy for nonmelanoma skin cancer-An analysis of 273 lesions. Brachytherapy. 17:601–608. doi:10.1016/j.brachy.2018.01.002.

LoConte NK, Gershenwald JE, Thomson CA, Crane TE, Harmon GE, Rechis R. 2018 May. Lifestyle Modifications and Policy Implications for Primary and Secondary Cancer Prevention: Diet, Exercise, Sun Safety, and Alcohol Reduction. Am Soc Clin Oncol Educ Book.:88–100. doi:10.1200/EDBK_200093.

Łaniewski P, Barnes D, Goulder A, Cui H, Roe DJ, Chase DM, Herbst-Kralovetz MM. 2018. Linking cervicovaginal immune signatures, HPV and microbiota composition in cervical carcinogenesis in non-Hispanic and Hispanic women. Sci Rep. 8:7593. doi:10.1038/s41598-018-25879-7.

Sun V, Crane TE, Slack SD, Yung A, Wright S, Sentovich S, Melstrom K, Fakih M, Krouse RS, Thomson CA. 2018. Rationale, development, and design of the Altering Intake, Managing Symptoms (AIMS) dietary intervention for bowel dysfunction in rectal cancer survivors. Contemp Clin Trials. 68:61–66. doi:10.1016/j.cct.2018.03.010.

Mowlazadeh Haghighi S, Zhou Y, Dai J, Sawyer JR, Hruby VJ, Cai M. 2018. Replacement of Arg with Nle and modified D-Phe in the core sequence of MSHs, Ac-His-D-Phe-Arg-Trp-NH, leads to hMC1R selectivity and pigmentation. Eur J Med Chem. 151:815–823. doi:10.1016/j.ejmech.2018.04.021.